Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 157 transactions and raising C$9.0 billion on behalf of our clients as of Q2/231.

Filter our transactions* using the categories below:

Imagesound
May 2022

Imagesound

Exclusive Financial Adviser (Sell side)
TECHNOLOGY FINANCIAL SPONSORS M&A ADVISORY UK
View transaction detail
Beeks Financial Cloud Group plc
£17.8m
April 2022

Beeks Financial Cloud Group plc

Adviser, Sole Broker and Sole Bookrunner
CORPORATE BROKING TECHNOLOGY UK
View transaction detail
Restore Plc
£603m
April 2022

Restore Plc

Joint Broker
BUSINESS SERVICES CORPORATE BROKING UK
View transaction detail
Intigriti
April 2022

Intigriti

Financial Adviser (Sell side)
TECHNOLOGY M&A ADVISORY BELGIUM UK
View transaction detail
Celadon Pharmaceuticals Plc
£8.5m
March 2022

Celadon Pharmaceuticals Plc

Nomad, Financial Adviser and Sole Broker
CORPORATE BROKING CANNABIS UK
View transaction detail
Search Laboratory
March 2022

Search Laboratory

Financial Adviser (Sell side)
TECHNOLOGY M&A ADVISORY UK FRANCE
View transaction detail
Phrasee
March 2022

Phrasee

Exclusive Financial Adviser (Sell side)
TECHNOLOGY M&A ADVISORY UK
View transaction detail
Air Partner
£84.8m
March 2022

Air Partner

Rule 3 Financial Adviser (Sell side)
INDUSTRIALS/AEROSPACE & DEFENSE M&A ADVISORY UK
View transaction detail
Lumi Global
March 2022

Lumi Global

Financial Adviser (Sell side)
TECHNOLOGY M&A ADVISORY UK
View transaction detail
Novartis
March 2022

Novartis

Financial Adviser (Sell side)
HEALTHCARE M&A ADVISORY SWITZERLAND UK
View transaction detail
John Lawrie Metals
February 2022

John Lawrie Metals

Financial Advisor
METALS AND MINING M&A ADVISORY UK
View transaction detail
Datapharm
February 2022

Datapharm

Financial Adviser (Sell side)
HEALTHCARE M&A ADVISORY UK
View transaction detail
  1. Company information as of September 30, 2022

* Transactions displayed here include transactions of Canaccord Genuity and its predecessors. The logos used in the tombstones represent Canaccord Genuity’s clients unless otherwise specified in the transaction description

How can we help?

If you would like to find out more about Canaccord Genuity or any of our services, please get in touch.